Affordable testing kits on the horizon to help further awareness as well as screening of the genetic blood disorder, ...

To understand the complement system’s involvement in ACS, Stowell and his team assessed the blood of 27 sickle-cell-disease patients experiencing ACS for signs of complement activation.

A team led by UT Southwestern Medical Center researchers has uncovered the atomic structure of a protein complex pivotal to ...

Inside each cell of the human body are proteins that control which genes are expressed at the right place and time. However, intriguingly, many of the most important proteins involved in gene ...

Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

A drug from Fulcrum Therapeutics showed promise in a sickle cell study, raising the possibility that a pill could be an ...

So far in 2025, the Trump administration has cut more than $1 billion in NIH grants. That includes a study on sickle cell disease, a blood disorder that affects roughly 100,000 people in the U.S ...

If successful, the access model for sickle cell disease gene therapies could serve as a blueprint for other such treatments ...

The algorithm helps providers better determine which kids should be admitted and who should go home for treatment with close hospital follow-up ...

In the ERC project HelixMold, a team from TU Graz developed a method for the computer-based design of artificial proteins, with a focus on custom biocatalysts for pharmaceutical applications or the ...